The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancer.
about
Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.Using antibodies to target cancer therapeutics.Shotgun proteomics of archival triple-negative breast cancer samples.GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates.New agents for the management of resistant metastatic breast cancer.
P2860
The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The use of an antibody drug co ...... he treatment of breast cancer.
@en
The use of an antibody drug co ...... he treatment of breast cancer.
@nl
type
label
The use of an antibody drug co ...... he treatment of breast cancer.
@en
The use of an antibody drug co ...... he treatment of breast cancer.
@nl
prefLabel
The use of an antibody drug co ...... he treatment of breast cancer.
@en
The use of an antibody drug co ...... he treatment of breast cancer.
@nl
P2860
P1476
The use of an antibody drug co ...... he treatment of breast cancer.
@en
P2093
Christopher H Keir
P2860
P304
P356
10.1517/14712598.2012.642357
P407
P577
2012-01-09T00:00:00Z